Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Cheng

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
The Laryngoscope|March 2, 2023
Differences in Efficacy and Safety of Sirolimus and Sildenafil in Pediatric Lymphatic MalformationsJialu Wang, Xuexi Zhang, Nian Sun, et al.
Annals of Hematology|June 8, 2026
Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world studyXi Lin, Yuntian Wang, Yunqi Zhu, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2016
The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE StudyWanru Yao, Juan Xiao, Xiaoling Cheng, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trialZhengping Li, Zekun Li, Xiaoling Cheng, et al.
Circulation Research|February 2, 2022
CIRKIL Exacerbates Cardiac Ischemia/Reperfusion Injury by Interacting With Ku70Hongwen Xiao, Mingyu Zhang, Hao Wu, et al.
Journal of Hematology & Oncology|April 9, 2026
Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trialRunhui Wu, Ju Gao, Yufeng Liu, et al.
Cell Stem Cell|April 12, 2025
An erythroid-biased FOS<sup>hi</sup> hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxiaWeili Liu, Xiaoru Zhang, Jinhua Liu, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Laryngoscope|March 2, 2023
Differences in Efficacy and Safety of Sirolimus and Sildenafil in Pediatric Lymphatic MalformationsJialu Wang, Xuexi Zhang, Nian Sun, et al.
Annals of Hematology|June 8, 2026
Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world studyXi Lin, Yuntian Wang, Yunqi Zhu, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2016
The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE StudyWanru Yao, Juan Xiao, Xiaoling Cheng, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trialZhengping Li, Zekun Li, Xiaoling Cheng, et al.
Circulation Research|February 2, 2022
CIRKIL Exacerbates Cardiac Ischemia/Reperfusion Injury by Interacting With Ku70Hongwen Xiao, Mingyu Zhang, Hao Wu, et al.
Journal of Hematology & Oncology|April 9, 2026
Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trialRunhui Wu, Ju Gao, Yufeng Liu, et al.
Cell Stem Cell|April 12, 2025
An erythroid-biased FOS<sup>hi</sup> hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxiaWeili Liu, Xiaoru Zhang, Jinhua Liu, et al.
Pageof 15